Drug Discovery

Is pharma now ushering in a new era of precision in neuroscience R&D?

Traversing the blood-brain-barrier using nanoparticle technology.

Parkinson’s UK is accelerating drug development through its virtual biotech.

How to add value and reduce risks with ethics.

We have vaccines. Now, pharma’s mission is to address novel variants. And vaccine hesitancy.

How will astronauts make medicines in space?

Ensuring that options for patients living with rare diseases aren’t scarce.

New approaches are underway for treating nonalcoholic steatohepatitis.

Sitting down with Janssen's David Lee to discuss a new era in immunology R&D.

Can prodrug payloads lead to a new dawn for antibody drug conjugates?